Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2343 ARTíCULOS , VIENDO DEL 2236 AL 2250

PUBMED

Meta-Analysis of the Relationship between Deep Brain Stimulation in Patients with Parkinson's Disease and Performance in Evaluation Tests for Executive Brain Functions.

Martínez-Martínez AM, Aguilar OM, Acevedo-Triana CA.

Parkinsons Dis. 2017;2017:9641392. doi: 10.1155/2017/9641392. Epub 2017 Feb 8. Review.

0

0

0

PUBMED

Brain structural and functional signatures of impulsive-compulsive behaviours in Parkinson's disease.

Imperiale F, Agosta F, Canu E, Markovic V, Inuggi A, Jecmenica-Lukic M, Tomic A, Copetti M, Basaia S, Kostic VS, Filippi M.

Mol Psychiatry. 2017 Mar 7. doi: 10.1038/mp.2017.18. [Epub ahead of print]

0

0

0

PUBMED

Non-Motor Symptoms Assessed by Non-Motor Symptoms Questionnaire and Non-Motor Symptoms Scale in Parkinson's Disease in Selected Asian Populations.

Sauerbier A, Jitkritsadakul O, Titova N, Klingelhoefer L, Tsuboi Y, Carr H, Kumar H, Banerjee R, Erro R, Bhidayasiri R, Schrag A, Zis P, Lim SY, Al-Hashel JY, Kamel WA, Martinez-Martin P, Ray Chaudhur

Neuroepidemiology. 2017 Aug 12;49(1-2):1-17. doi: 10.1159/000478702. [Epub ahead of print]

0

0

0

PUBMED

Parkinson's disease susceptibility variants and severity of Lewy body pathology.

Heckman MG, Kasanuki K, Diehl NN, Koga S, Soto A, Murray ME, Dickson DW, Ross OA.

Parkinsonism Relat Disord. 2017 Sep 11. pii: S1353-8020(17)30334-6. doi: 10.1016/j.parkreldis.2017.09.009. [Epub ahead of print]

0

0

0

PUBMED

Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene.

Ma D, Zhou W, Ng EY, Zeng L, Zhao Y, Tan EK.

Stem Cell Res. 2017 Jan;18:45-47. doi: 10.1016/j.scr.2016.12.011. Epub 2016 Dec 10.

0

0

0

PUBMED

Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.

Latourelle JC, Beste MT, Hadzi TC, Miller RE, Oppenheim JN, Valko MP, Wuest DM, Church BW, Khalil IG, Hayete B, Venuto CS.

Lancet Neurol. 2017 Sep 25. pii: S1474-4422(17)30328-9. doi: 10.1016/S1474-4422(17)30328-9. [Epub ahead of print]

0

0

0

PUBMED

Diagnostic exome sequencing in early-onset Parkinson's disease confirms VPS13C as a rare cause of autosomal-recessive Parkinson's disease.

Schormair B, Kemlink D, Mollenhauer B, Fiala O, Machetanz G, Roth J, Berutti R, Strom TM, Haslinger B, Trenkwalder C, Zahorakova D, Martasek P, Ruzicka E, Winkelmann J.

Clin Genet. 2017 Sep 1. doi: 10.1111/cge.13124. [Epub ahead of print]

0

0

0

PUBMED

Device-Aided Treatment Strategies in Advanced Parkinson's Disease.

Timpka J, Nitu B, Datieva V, Odin P, Antonini A.

Int Rev Neurobiol. 2017;132:453-474. doi: 10.1016/bs.irn.2017.03.001. Epub 2017 May 8.

0

0

0

PUBMED

My 25 Stimulating Years with DBS in Parkinson's Disease.

Hariz M.

J Parkinsons Dis. 2017;7(s1):S35-S43. doi: 10.3233/JPD-179007.

0

0

0

PUBMED

Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease.

Elgueta D, Aymerich MS, Contreras F, Montoya A, Celorrio M, Rojo-Bustamante E, Riquelme E, González H, Vásquez M, Franco R, Pacheco R.

Neuropharmacology. 2017 Feb;113(Pt A):110-123. doi: 10.1016/j.neuropharm.2016.09.028.

0

0

0

PUBMED

Parkinson's Disease Is Not Simply a Prion Disorder.

Surmeier DJ, Obeso JA, Halliday GM.

J Neurosci. 2017 Oct 11;37(41):9799-9807. doi: 10.1523/JNEUROSCI.1787-16.2017. Review.

0

0

0

PUBMED

Current Practice and the Future of Deep Brain Stimulation Therapy in Parkinson's Disease.

Almeida L, Deeb W, Spears C, Opri E, Molina R, Martinez-Ramirez D, Gunduz A, Hess CW, Okun MS.

Semin Neurol. 2017 Apr;37(2):205-214. doi: 10.1055/s-0037-1601893. Epub 2017 May 16.

0

0

0

PUBMED

Brain metabolic correlates of fatigue in Parkinson's disease: A PET study.

Zhang L, Li T, Yuan Y, Tong Q, Jiang S, Wang M, Wang J, Ding J, Xu Q, Zhang K.

Int J Neurosci. 2017 Sep 18:1-16. doi: 10.1080/00207454.2017.1381093. [Epub ahead of print]

0

0

0

PUBMED

The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy.

Longhena F, Faustini G, Missale C, Pizzi M, Spano P, Bellucci A.

Neural Plast. 2017;2017:5012129. doi: 10.1155/2017/5012129. Review.

0

0

0

PUBMED

Rosacea and subsequent diagnosis for Parkinson's Disease: a large, urban, single center, U.S. patient population retrospective study.

Mathieu RJ, Guido N, Ibler E, Serrano L, Rangel SM, Schlosser BJ, West DP, Laumann AE, Nardone B.

J Eur Acad Dermatol Venereol. 2017 Oct 12. doi: 10.1111/jdv.14638. [Epub ahead of print]

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy